Related Experiment Video
Updated: Sep 5, 2026

Preparation of Zinc Oxide Nanoparticles and the Evaluation of their Antibacterial Effects
Published on: September 27, 2024
Ruthenium complexes as potent antibiotics in methicillin-resistant Staphylococcus aureus (MRSA) via membrane damage
Wen-Ping Wang1, Wei Deng1, Jin-Tao Wang1
1School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang 330013, China.
Abstract:
With the growing crisis of multidrug-resistant bacterial infections, a series of novel ruthenium complexes were rationally designed and synthesized to disrupt the integrity of bacterial membranes. In vitro antibacterial screening demonstrated that the lead compound Ru-6 possesses potent bactericidal activity against multiple methicillin-resistant Staphylococcus aureus (MRSA) isolates, with minimum inhibitory concentrations (MICs) ranging from 1.56 to 6.25 μg/mL. Concurrently, Ru-6 displayed negligible hemolytic toxicity toward rabbit erythrocytes. Mechanistic studies suggest that Ru-6 exerts its antibacterial effects through a dual-pathway mechanism: phosphatidylglycerol (PG) acts as a potential membrane interaction partner for Ru-6, facilitating bacterial membrane damage; and also Ru-6 treatment triggers elevated reactive oxygen species (ROS) levels, which is speculated to mediate subsequent intracellular injury. Transcriptomic analysis further revealed that Ru-6 modulates the regulation of bacterial internal genes. In vivo experiments (mouse skin wound infection and Galleria mellonella infection models) confirmed that Ru-6 effectively eradicates MRSA without significant toxicity to host tissues. Ru-6 exhibits considerable potential as a novel antimicrobial agent for clinical application.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Staphylococcal Skin Infections
Inhibitors of Bacterial Protein Synthesis
Inhibitors of Gram-positive Cell Wall Synthesis
Development of Antibiotic Resistance
